Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Thiogenesis Therapeutics Logo
Thiogenesis Therapeutics Growth Score
62
CB Rank
15738
Heat Score
86
Thiogenesis Therapeutics is a clinical-stage biotech company that develops thiol-active therapeutics to treat medical diseases.
Founded
obfuscation
PublicPost-IPO Equity Toronto, Ontario, Canada1-10 www.thiogenesis.com/
Biotechnology
Health Care
Medical
Therapeutics
Overview

Thiogenesis Therapeutics
Total Funding
obfuscation
Growth Score
62
Heat Score
86

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score62
-10 pts
in past quarter
Heat Score 86
20 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Thiogenesis Therapeutics

CB Rank
15738
Thiogenesis Therapeutics is a clinical-stage biotech company that develops thiol-active therapeutics to treat medical diseases.
Founded
obfuscation
PublicPost-IPO Equity Toronto, Ontario, Canada1-10 www.thiogenesis.com/
Biotechnology
Health Care
Medical
Therapeutics

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name Thiogenesis Therapeutics, Corp.
Operating Status Active
Stock Symbol  CSE:TTI
Company Type For Profit
Founders  Patrice Rioux
About the Company
Thiogenesis Therapeutics is a clinical-stage biotech company that develops thiol-active therapeutics to treat medical diseases.
Contact Email info@thiogenesis.com
Predictions & Insights

Growth Insight

See this Growth Insight
Thiogenesis Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

TTI-0102
A prodrug thiol compound designed to deliver cysteamine with reduced side effects and improved dosing flexibility for mitochondrial and metabolic diseases.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Thiogenesis Therapeutics Logo
Post-IPO Equity - Thiogenesis Therapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Thiogenesis Therapeutics Logo
Post-IPO Equity - Thiogenesis Therapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Thiogenesis Therapeutics Logo
Post-IPO Equity - Thiogenesis Therapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Thiogenesis Therapeutics Logo
Post-IPO Equity - Thiogenesis Therapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Thiogenesis Therapeutics Logo
Post-IPO Equity - Thiogenesis Therapeutics
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Thiogenesis Therapeutics Logo
Post-IPO Equity - Thiogenesis Therapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Thiogenesis Therapeutics Logo
Post-IPO Equity - Thiogenesis Therapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Thiogenesis Therapeutics Logo
Post-IPO Equity - Thiogenesis Therapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Thiogenesis Therapeutics Logo
Post-IPO Equity - Thiogenesis Therapeutics
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Thiogenesis Therapeutics Logo
Post-IPO Equity - Thiogenesis Therapeutics
—
obfuscation
— Post-IPO Equity

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1 Contacts 1

Employee Profiles

News

News and Press

News•Jun 17, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 3, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 1, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 11, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

219
160.71%
 in past month

IT Spend

$63.8KThis year, Thiogenesis Therapeutics is projected to spend $63.8K on IT, according to Aberdeen.

Active Website Tech Count

3Thiogenesis Therapeutics is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  MailChimp.
Sub-Organizations
Frequently Asked Questions

Where is Thiogenesis Therapeutics's headquarters? Thiogenesis Therapeutics is located in Toronto, Ontario, Canada.When was the last funding round for Thiogenesis Therapeutics? Thiogenesis Therapeutics closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Thiogenesis Therapeutics's competitors? Alternatives and possible competitors to Thiogenesis Therapeutics may include BioAge Labs, Olatec Therapeutics, and  Astrogen, inc..How much funding has Thiogenesis Therapeutics raised to date? Thiogenesis Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8fe006b 1)
|